Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group


Click on country-registry for comparison

FlagCountry-registryRegistration periodNo. of casesMaleFemaleNumber of cases by age groupRelative survival by age group
5-year survival5-year survival
No.AbsRelNo.AbsRel<4545-5455-6465-7475+<4545-5455-6465-7475+
China - Shangai 1992-1995674254.870.22544.048.235192812101.682.751.657.772.2
China - Tianjin 1991-19991469385.2107.05367.576.4615376523101.389.696.987.2126.2
Singapore 1993-1997443125.629.71346.251.8261514750.534.621.968.80.0
Republic of Korea - Busan 1996-2001745644.951.71844.448.0810292160.062.556.739.20.0
Republic of Korea - Incheon 1997-2001342450.055.9102118103101.50.060.031.10.0
Republic of Korea - Seoul 1993-199714710370.681.64452.359.5102944511361.064.581.473.896.8
Thailand - Lampang 1990-2000393016.717.4955.657.366189033.833.823.023.90.0



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period